Development and validation of an LC-MS/MS method for the determination of tigecycline in human plasma and cerebrospinal fluid and its application to a pharmacokinetic study-Reference-Cited by-同舟云学术

Development and validation of an LC-MS/MS method for the determination of tigecycline in human plasma and cerebrospinal fluid and its application to a pharmacokinetic study

Published:2016-07-06 Issue:12 Volume:30 Page:1992-2002
ISSN:0269-3879
Container-title:Biomedical Chromatography
language:en
Short-container-title:Biomedical Chromatography

Author:

Mei Shenghui¹²,Luo Xuying³,Li Xingang¹²,Li Qian³,Huo Jiping¹,Yang Li¹²,Zhu Leting¹,Feng Weixing⁴,Zhou Jianxin³,Shi Guangzhi³,Zhao Zhigang¹²

Affiliation:

1. Department of Pharmacy, Beijing Tiantan Hospital; Capital Medical University; 6 TiantanXili, Dongcheng District Beijing 100050 People's Republic of China

2. Department of Clinical Pharmacology, College of Pharmaceutical Sciences; Capital Medical University; Beijing 100045 People's Republic of China

3. Intensive Care Unit, Beijing Tiantan Hospital; Capital Medical University; 6 TiantanXili, Dongcheng District Beijing 100050 People's Republic of China

4. Department of Neurology, Beijing Children's Hospital; Capital Medical University; Beijing 100045 People's Republic of China

Funder

Capital Medical University

National Natural Science Foundation of China

Publisher

Wiley

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Biology,General Medicine,Biochemistry,Analytical Chemistry

Reference34 articles.

1. The efficacy and safety of tigecycline for the treatment of complicated intra-abdominal infections: Analysis of pooled clinical trial data;Babinchak;Clinical Infectious Diseases: an Official Publication of the Infectious Diseases Society of America,2005

2. In vitro activity of tigecycline against isolates from patients enrolled in phase 3 clinical trials of treatment for complicated skin and skin-structure infections and complicated intra-abdominal infections;Bradford;Clinical Infectious Diseases: an Official Publication of the Infectious Diseases Society of America,2005

3. The methodology and pharmacokinetics study of intraventricular administration of vancomycin in patients with intracranial infections after craniotomy;Chen;Journal of Critical Care,2015

4. Effect of the anticoagulant ethylenediamine tetra-acetic acid (EDTA) on the estimation of pharmacokinetic parameters: A case study with tigecycline and ciprofloxacin;Chen;Xenobiotica,2008

5. Steady-state serum and intrapulmonary pharmacokinetics and pharmacodynamics of tigecycline;Conte;International Journal of Antimicrobial Agents,2005

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An "ON-OFF" fluorescent sensor based on a novel zinc-based flower-like structured metal-organic framework for sequential detection of deferasirox and tigecycline;Analytica Chimica Acta;2023-10

2. Analysis of tigecycline in the cerebrospinal fluid and serum of patients with Acinetobacter baumannii central nervous system infection;Bioanalysis;2023-09

3. Central composite design driven optimization of sustainable stability indicating HPLC method for the determination of Tigecycline and greenness assessment;F1000Research;2023-08-10

4. Clinical Experience with Off-Label Intrathecal Administration of Selected Antibiotics in Adults: An Overview with Pharmacometric Considerations;Antibiotics;2023-08-05

5. Portable Nanoparticle-Enhanced Sensor for Tigecycline Determination in Biological Fluids and in the Presence of Its Degradation Products;Journal of The Electrochemical Society;2023-08-01